You are here: Industry Insights > COVID-19 vaccine

News List

UK launches trial to study alternating COVID-19 vaccines for different doses europeanpharmaceuticalreview
February 07, 2021
The UK Government has given £7 million of funding for a clinical trial which will investigate whether patients can be given different COVID-19 vaccines for each dose.
Janssen seeks EUA for Covid-19 vaccine candidate from US FDA pharmaceutical-technology
February 07, 2021
Johnson & Johnson (J&J) unit Janssen Biotech has submitted an application seeking emergency use authorisation (EUA) for its investigational single-dose Covid-19 vaccine candidate to the US Food and Drug Administration (FDA).
Pfizer drops India vaccine application after regulator seeks local trial expresspharma
February 07, 2021
The decision means the vaccine will not be available for sale in the world’s two most populous countries, India and China, in the near future.
China grants conditional approval to 2nd COVID-19 vaccine expresspharma
February 07, 2021
China has granted conditional approval for its second COVID-19 vaccine, ahead of the expected emergency approval from the WHO for two of its jabs that would enable the country to step-up global supplies of the shots.
Multiple rolling reviews kick-off for Novavax’s COVID-19 vaccine pharmatimes
February 05, 2021
Rolling reviews of Novavax’s COVID-19 vaccine have kicked-off in the UK, US, EU and Canada following the recent announcement that the jab demonstrated 89.3% efficacy in a phase III trial.
Valneva Begins Manufacturing of Inactivated, Adjuvanted COVID-19 Vaccine, Completes Study Recruitment americanpharmaceuticalreview
February 05, 2021
Valneva has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine.
Moderna’s Covid-19 vaccine receives interim authorisation in Singapore pharmaceutical-technology
February 05, 2021
The Singapore Health Sciences Authority (HSA) has approved the interim authorisation of Moderna’s mRNA Covid-19 vaccine for use under the Pandemic Special Access Route (PSAR).
Malaysia sets February 2022 target to complete COVID-19 vaccine rollout expresspharma
February 05, 2021
Malaysia’s government said on Thursday it expects to complete its COVID-19 immunisation programme by February next year, covering 80 per cent of its population of about 32 million people.
New analysis backs safety, efficacy of AZ/Oxford COVID-19 jab pharmatimes
February 04, 2021
A primary analysis of late-stage trial data has backed the safety and efficacy of AstraZeneca/Oxford University's COVID-19 vaccine, with 100% protection against severe disease, hospitalisation and death.
UK trial will evaluate safety of mixing different COVID-19 vaccines pharmatimes
February 04, 2021
A new clinical study, based in the UK, will investigate alternating COVID-19 vaccine doses with the aim of examining whether different vaccines can safely be used for two-dose regimens.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page